Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Other Non-Current Assets: 2013-2025

Historic Other Non-Current Assets for Coherus Oncology (CHRS) over the last 11 years, with Sep 2025 value amounting to $4.4 million.

  • Coherus Oncology's Other Non-Current Assets fell 39.72% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 39.72%. This contributed to the annual value of $72.2 million for FY2024, which is 645.20% up from last year.
  • According to the latest figures from Q3 2025, Coherus Oncology's Other Non-Current Assets is $4.4 million, which was down 11.77% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Coherus Oncology's Other Non-Current Assets registered a high of $72.2 million during Q4 2024, and its lowest value of $4.4 million during Q3 2025.
  • Moreover, its 3-year median value for Other Non-Current Assets was $7.8 million (2023), whereas its average is $13.2 million.
  • Per our database at Business Quant, Coherus Oncology's Other Non-Current Assets skyrocketed by 2,341.82% in 2021 and then tumbled by 39.72% in 2025.
  • Coherus Oncology's Other Non-Current Assets (Quarterly) stood at $10.0 million in 2021, then decreased by 13.54% to $8.7 million in 2022, then rose by 11.74% to $9.7 million in 2023, then surged by 645.20% to $72.2 million in 2024, then slumped by 39.72% to $4.4 million in 2025.
  • Its Other Non-Current Assets stands at $4.4 million for Q3 2025, versus $5.0 million for Q2 2025 and $5.7 million for Q1 2025.